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der or birth weight on the effects of body composition mea-
sures.  Conclusions: Our results do not support previous 
studies showing associations between  INS VNTR and  IGF1 
promoter region polymorphisms with body composition in 
early childhood. 
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 Introduction 
 Common polymorphisms of the insulin gene variable 
number of tandem repeats ( INS VNTR) and the insulin-
like growth factor 1  (IGF1) are associated with variations 
in early growth and body composition  [1] .  INS VNTR is 
known to have functional effects on circulating insulin 
levels, which may influence fetal and early postnatal 
growth  [2] . Several studies have suggested that this poly-
morphism is associated with size at birth, childhood and 
adult obesity, type 2 diabetes and insulin resistance  [3–5] . 
However, thus far, findings seem to be rather inconsistent 
 [1, 4, 6] . We have previously found an association of  INS 
VNTR with a gestational duration but not with birth 
weight  [4] . A common promoter region polymorphism of 
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 Abstract 
 Objective: The objective of this study was to examine the 
associations between insulin gene variable number of tan-
dem repeats ( INS VNTR) and insulin-like growth factor 1 
 (IGF1) gene promoter region polymorphisms with body 
composition in early childhood.  Methods: This study was 
embedded in an ongoing prospective cohort study. Growth 
in early childhood (body mass index, total subcutaneous fat 
mass and waist-hip ratio) was assessed at birth and at the 
ages of 6 weeks and 24 months. DNA for genotyping was 
available in 738 children.  Results: The genotype distribution 
of the  INS VNTR gene was I/I 50.4%, I/III 40.4%, and III/III 9.2%. 
 IGF1 genotypes were categorized in the following categories 
based on their 192-bp allele: homozygous (wild-type) 43.1%, 
heterozygous 45.8%, and noncarrier 11.2%. No differences 
were found in body mass index, total subcutaneous fat mass 
and waist-hip ratio in early childhood between the three 
groups for both the  INS VNTR and  IGF1 genotypes. We also 
did not find interactions between these genotypes and gen-
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the  IGF1 gene, which is associated with circulating IGF-1 
levels, has been suggested to affect birth weight, adult 
height and the risk of type 2 diabetes  [1, 7–11] . We and 
others could not replicate an association between vari-
ants of the  IGF1 promoter region and birth weight  [1, 12, 
13] . Also, we could not replicate previously suggested as-
sociations of this polymorphism with weight gain during 
infancy  [1] .
 Both polymorphisms have also been suggested to be 
associated with various measures of body composition, 
such as body mass index (BMI), fat mass and waist cir-
cumference  [1, 3, 5, 11, 14, 15] . To our knowledge, no stud-
ies have examined the associations of these common 
polymorphisms with body composition in infancy and 
early childhood. It is known that measures of body com-
position track from early childhood onwards  [16–18] . 
The genetic component of variations in body composi-
tion may be larger in early life when the effects of lifestyle 
habits may be limited.
 Therefore, in addition to our previous reports focused 
on associations between  INS VNTR and  IGF1 gene poly-
morphisms with weight and height in fetal life and early 
infancy  [4, 13] , this study examined in the same prena-
tally recruited prospective cohort study, the associations 
of  INS VNTR and  IGF1 gene polymorphism with differ-
ent measures of body composition at the ages of 6 weeks 
and 24 months.
 Subjects and Methods 
 Design 
 This study was embedded in the Generation R Study, a pro-
spective cohort study from fetal life until young adulthood in Rot-
terdam, The Netherlands. This study is designed to identify early 
environmental and genetic determinants of growth, development 
and health from early fetal life onwards  [19, 20] . In total, the co-
hort includes 9,778 mothers and their children. Additional, more 
detailed assessments of fetal and postnatal growth and develop-
ment were conducted in a subgroup of 1,232 parents and their 
children, referred to as the Generation R Focus cohort. This sub-
group is homogeneously ethnic to exclude possible confounding 
or effect modification by ethnicity. Of all approached women, 
80% were enrolled in this subgroup study in late pregnancy (ges-
tational age of 30 weeks). In this subgroup, postnatal examina-
tions were performed at the ages of 6 weeks and 24 months. The 
study has been approved by the Medical Ethics Committee of the 
Erasmus Medical Center, Rotterdam. Written informed consent 
was obtained from all participants or their parents.
 Population for Analysis 
 In total, 1,232 women were enrolled in the Generation R Focus 
Study. Pregnancies leading to perinatal death (n = 2) were exclud-
ed from the present analysis. DNA was collected from cord blood 
and available for 884 subjects. In total, 744 children were included 
in this study, of whom genotyping for  INS VNTR and  IGF1 gene 
was successful in 738 and 627 children, respectively. Missing cord 
blood samples were mainly due to logistical and clinical con-
straints during delivery. Response rates for DNA samples were 
lower among complicated pregnancies and deliveries.
 Genotyping Assays INS  VNTR and IGF1  Gene 
 DNA was collected from cord blood samples of the children at 
birth. For  INS VNTR polymerase chain reaction was performed 
to amplify the –23/ Hph I single nucleotide polymorphism (A/T), 
which is known to be in almost complete linkage disequilibrium 
with  INS VNTR class  [21] . The  INS VNTR genotypes were catego-
rized in three classes: I/I, I/III and III/III.  INS VNTR is imprint-
ed with the paternally inherited allele being expressed  [22] . The 
I/III heterozygote group can be considered as an indeterminate 
group, consisting partly of individuals in whom the I allele is ex-
pressed and partly of individuals in whom the III allele is ex-
pressed. Therefore, although the I/III and III/III genotype groups 
were both separately compared with the I/I group (reference 
group), the main interest in our analyses was on the difference 
between the I/I and the III/III heterozygous subjects.
 As for  IGF1, polymerase chain reaction was performed using 
oligonucleotide primers designed to amplify the polymorphic cy-
tosine-adenine repeat 1 kb upstream of the human  IGF1 gene as 
previously described  [13, 23] . As in former studies,  IGF1 geno-
types were categorized in the following categories based on their 
192-bp allele: homozygous (wild-type), heterozygous and noncar-
rier  [1, 10, 12, 13, 24] . In both polymorphisms, the genotype dis-
tribution was similar to those found in previous studies and the 
frequency distribution did not deviate from the Hardy-Weinberg 
equilibrium  [1, 3, 9, 25] .
 Body Composition 
 At the ages of 6 weeks and 24 months, all subjects were invited 
to the research center. Four well-trained medical assistants took 
all measurements. Anthropometrics were measured without 
clothes.
 Weight was measured to the nearest gram using an electronic 
scale (Seca  ) at 6 weeks of age and a mechanical scale (Seca  ) at 
24 months of age. Height was measured to the nearest millimeter 
in supine position using a neonanometer (Holtain Limited  ) at 
the age of 6 weeks and in standing position by a Harpender stadi-
ometer (Holtain Limited  ) at the age of 24 months. BMI was cal-
culated as weight/height 2 (kg/m 2 ). At 6 weeks, we calculated pon-
deral index (weight/height 3 (kg/m 3 )), because this measurement 
is known to be a better indicator for body composition in new-
borns than BMI  [26] .
 Subcutaneous fat mass (mm) was measured by skin fold thick-
nesses (SFTs), which are valid measurements for use in epidemio-
logical studies  [27, 28] . SFTs were measured under standard con-
ditions by using a standard skin fold caliper (SlimGuide; Creative 
Health Products  ). Measurements were taken, as previously de-
scribed, on the left side of the body at four different sites: triceps, 
biceps, subscapular and suprailiacal  [27] . The consensus between 
and among observers for the medical assistants was analyzed us-
ing the intraclass correlation coefficient (ICC). Intraobserver ICC 
was 0.88 and interobserver ICC was 0.76  [29, 30] . The skin fold 
caliper was operated with a constant pressure of 10 g/mm 3 . Total 
subcutaneous fat mass (TSFM) (mm) was calculated from the 
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sum of triceps SFT + biceps SFT + subscapular SFT + suprailiacal 
SFT  [29] .
 Waist circumference was measured at the minimum circum-
ference between the iliac crest and the rib cage and hip circumfer-
ence was measured at the maximum width over the greater tro-
chanters using a flexible steel tape to the nearest millimeter. 
Waist-hip ratio (WHR) was then calculated as waist circumfer-
ence divided by hip circumference.
 Covariates 
 Information on maternal age, parity and weight before preg-
nancy was obtained by a questionnaire at the enrolment in the 
study. Maternal smoking habits were assessed in each question-
naire. Maternal height was measured without shoes at our re-
search center. BMI (weight before pregnancy/height 2 ) was calcu-
lated. Birth weight, date of birth and gender were obtained from 
community midwife and hospital registries.
 Data Analysis 
 Power calculation was based on previous studies showing as-
sociations of  INS VNTR and  IGF1 with measures of body compo-
sition  [1, 3, 5, 9, 14, 15] . With a genotype frequency of 10%, a dif-
ference of 0.3 standard deviation can be detected (type I error 5%, 
type II error 20%, and power 80%). This difference is much small-
er than shown in previous studies. Multiple linear regression 
models were performed to assess the associations of the  INS 
VNTR with BMI, TSFM and WHR at the ages of 6 weeks and 24 
months cross-sectionally. These models were adjusted for gender 
and current age. To take account for differences between observ-
ers, we have also adjusted the analyses for the specific observer as 
covariate. Age, weight, height, BMI and smoking habits of the 
mother and parity did not change the effect estimates and were 
therefore not included in the final analyses. Subsequently, we test-
ed the interaction of  INS VNTR with gender and birth weight. 
Similar analyses as for  INS VNTR were performed for the  IGF1 
gene. Additionally, we used a different stratification of genotype 
groups; presence and absence of 192/194 bp. Recent studies have 
shown that subjects who were homozygous for the 192-bp or the 
194-bp allele had comparable IGF-1 blood levels, while individu-
als who were homozygous for either alleles shorter than 192 bp or 
longer than 194 bp had significantly lower serum IGF-1 levels  [11, 
31, 32] . Therefore, we assumed that all subjects who were homo-
zygous for 192 or 194 bp or were carriers of both the 192-bp allele 
and the 194-bp allele could be regarded as the wild-type group. 
Consequently, all subjects who were carriers of at least one variant 
allele (either less than 192 bp or more than 194 bp) were grouped 
as variant carriers. All measures of association are presented with 
their 95% confidence intervals (CI). All statistical analyses were 
performed using the Statistical Package of Social Sciences version 
11.0 for Windows (SPSS, Inc., Chicago, Ill., USA).
 Results 
 A total of 744 subjects were included in the study. Ma-
ternal and child characteristics are shown in  table 1 , as 
well is the genotype frequency distribution. The DNA for 
genotyping of  INS VNTR was available in 738 subjects. 
The  IGF1 promoter region was determined in 627 sub-
jects. Gender distribution was similar in the genotype 
groups for both genes. At 6 weeks, 657 subjects partici-
pated in the postnatal assessment, at 2 years this number 
was 629.
 The  INS VNTR genotype distribution in this study 
was 50.4, 40.4 and 9.2% for class I/I, I/III and III/III, re-
Table 1. Maternal and child characteristics and genotype fre-
quency distribution
Maternal characteristics n = 744
Age, years 32.1 (31.5–32.1)
Weight before pregnancy, kg 69.0 (12.7)
Height, cm 171.0 (6.4)
BMI 23.5 (4.1)
Parity, nulliparous 59.7%
Smoking
No 70.4%
Yes, until pregnancy 9.0%
Yes, throughout pregnancy 11.8%
Birth characteristics n = 744
Gestational age, weeks 40.3 (39.9–40.2)
Weight, g 3,516 (523)
Gender, boys 51.9%
Postnatal characteristics 6 weeks n = 657
Age at visit, weeks 6.3 (6.6–6.9)
Weight, g 4,892 (697)
Height, cm 56.8 (2.6)
BMI 15.1 (1.4)
TSFM, mm 23.6 (7.0)
Ponderal index, kg/m3 26.7 (2.5)
Postnatal characteristics 24 months n = 629
Age at visit, months 25.1 (25.3–25.4)
Weight, g                                               12,672 (1,405)
Height, cm 89.1 (3.2)
BMI 16.0 (1.3)
TSFM, mm 27.1 (6.6)
WHR 0.99 (0.05)
INS VNTR class genotype n = 738
I/I 50.4%
I/III 40.4%
III/III 9.2%
IGF1 genotype n = 627
Homozygous 43.1%
Heterozygous 45.8%
Noncarrier 11.2%
Values are means (SDS), medians (95% range) for variables 
with skewed distribution or percentages. Of the total group, data 
were missing on maternal weight and BMI before pregnancy (n = 
127), parity (n = 1) and smoking habits (n = 65). The allele distri-
bution is based on 2 alleles per infant.
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spectively ( table 1 ). Differences in BMI, TSFM and WHR 
between the genotype groups at each age are given in  fig-
ure 1 . These estimated differences were based on multiple 
linear regression models and genotype group I/I was used 
as reference. No statistically significant associations (p  1 
0.05) were found with the different measurements of 
body composition at 6 weeks and 24 months.
 Subsequently we looked at the interaction of  INS 
VNTR with gender and birth weight at 6 weeks. We did 
not find a significant association between these determi-
nants. In  table 2 the association of  INS VNTR with BMI, 
TSFM and WHR at 24 months stratified by gender is pre-
sented. No significant differences in any measure of body 
composition between the different genotypes were pres-
ent in boys or girls.
 For the  IGF1 gene, 43.1% subjects were 192 bp homo-
zygous, 45.8% were 192 bp heterozygous, and 11.2% sub-
jects were noncarriers. Again no significant differences 
were observed in the maternal, birth and postnatal char-
acteristics between these three groups.  Figure 2 repre-
sents the differences in BMI, TSFM and WHR at 6 weeks 
and 24 months between the  IGF1  genotype groups. No 
differences in body composition were found at any age 
and no significant association was found in the interac-
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 Fig. 1.  INS VNTR gene promoter region 
polymorphism and body composition in 
early childhood.  a–c Mean differences 
(and the 95% CI) in body composition ac-
cording to  INS VNTR genotype at 6 weeks 
and 24 months of age based on multiple 
linear regression models. The I/I group is 
used as reference group and the models are 
adjusted for gender and age. 
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tion of  IGF1 genotype with gender and birth weight at 6 
weeks. The association between  IGF1 genotype and body 
composition at 24 months by gender is shown in  table 3 . 
No differences in body composition were found.
 Classification of the  IGF1 gene promoter polymor-
phism based on the presence and absence of the 192-/194-
bp allele genotypes showed that this genotype was present 
in 442 (70.5%) and absent in 182 (29.5%) subjects. Again 
no differences were found in body composition in early 
childhood between the two groups (data not shown).
 There were no differences found in ponderal index at 
6 weeks in the variant carriers of  INS VNTR (differences: 
–0.05 (95% CI –0.76, 0.67) kg/m 3 ) and  IGF1 genotypes 
(differences: –0.19 (95% CI –0.92, 0.54) kg/m 3 ).
 Discussion 
 In this population-based prospective cohort study, the 
associations between a polymorphism in  INS VNTR and 
in the promoter region of the  IGF1 gene and parameters 
of body composition were investigated. Body composi-
tion was measured by BMI, TSFM and WHR. No differ-
ences were found in these polymorphisms in relation to 
body composition.
 To our knowledge, this study is the first prospective 
cohort that examined the association between polymor-
phisms in the  INS VNTR and  IGF1 gene and body com-
position in early childhood. DNA was collected from 
cord blood and available for 884 subjects. In total, 744 
children were included in this study, of whom genotyping 
for  INS VNTR and  IGF1 gene was successful in 738 and 
627 subjects, respectively. Missing cord blood and DNA 
samples were mainly due to logistical and clinical con-
straints during delivery. Response rates for DNA samples 
were lower among complicated pregnancies and deliver-
ies. As a consequence, children who were not genotyped 
had a shorter gestational age at birth (difference: –0.49 
(95% CI –0.73, –0.25) weeks, p  ! 0.01) and a lower birth 
weight (difference: –108.0 (95% CI –182.1, –0.34.0) grams, 
p  ! 0.01). The numbers of children with low birth weight
(n = 12) or preterm birth (n = 25) were lower than ex-
pected. Lack of variation in birth weight could lead to an 
underestimation of the effect. However, previous studies 
did not consistently show associations between these two 
genetic variants and birth weight. Measurements of body 
composition were available in 657 (88%) subjects at 6 
weeks and in 629 (85%) subjects at 24 months. Our effect 
estimates would be biased or underestimated if the asso-
ciations between  INS VNTR and  IGF1 genotype and 
Table 2. Associations of INS VNTR genotypes with body compo-
sition at 24 months by gender
INS VNTR
class genotype
Boys Girls
Difference in BMI
I/I reference reference
I/III –0.13 (–0.45, 0.19) 0.04 (–0.28, 0.36)
III/III 0.30 (–0.22, 0.83) 0.13 (–0.44, 0.71)
Difference in TSFM, mm
I/I reference reference
I/III –0.15 (–1.85, 1.55) 1.12 (–0.53, 2.77)
III/III 1.22 (–1.59, 4.03) 0.61 (–2.28, 3.50)
Difference in WHR
I/I reference reference
I/III 0.01 (–0.01, 0.02) 0.00 (–0.01, 0,01)
III/III 0.01 (–0.01, 0.03) 0.02 (–0.01, 0.04)
Values are regression coefficients (95% CI) and reflect the dif-
ference in body composition. Differences are adjusted for current 
age. Analyses are based on the following numbers: boys: I/I, n = 
129 (45%), I/III, n = 131 (45%) and III/III, n = 30 (10%); girls: I/I, 
n = 154 (55%), I/III, n = 105 (37%) and III/III, n = 22 (8%).
Table 3. Associations of IGF1 genotypes with body composition 
at 24 months by gender
IGF1 genotype Boys Girls
Difference in BMI
Homozygous reference reference
Heterozygous –0.05 (–0.41, 0.32) –0.23 (–0.57, 0.12)
Noncarrier 0.05 (–0.48, 0.58) –0.39 (–0.98, 0.20)
Difference in TSFM, mm
Homozygous reference reference 
Heterozygous 0.04 (–1.88, 1.97) –1.15 (–2.84, 0.54)
Noncarrier –0.46 (–3.10, 2.19) –2.04 (–5.07, 0.99)
Difference in WHR
Homozygous reference reference
Heterozygous 0.01 (0.00, 0.02) 0.00 (–0.01, 0,02)
Noncarrier 0.01 (–0.01, 0.03) 0.00 (–0.03, 0.02)
Values are regression coefficients (95% CI) and reflect the dif-
ference in body composition. Differences are adjusted for current 
age. Analyses are based on the following numbers: boys: homozy-
gous, n =107 (43%), heterozygous, n = 108 (44%) and noncarrier, 
n = 33 (13%); girls: homozygous, n = 97 (40%), heterozygous, n = 
120 (50%) and noncarrier, n = 23 (10%).
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growth characteristics differ between those with and 
without complete data. This seems unlikely but cannot be 
excluded. However, generalization of our results to chil-
dren born preterm or with low birth weight is limited.
 Previous studies have shown a relationship between 
the  INS VNTR genotype and body composition. The class 
III genotype was associated with larger BMI, body weight, 
fat mass and waist circumference  [3, 5, 14, 15] . These stud-
ies concluded that subjects homozygous for the  INS VNTR 
class III allele may have a larger tendency to gain weight 
through the accumulation of fat, which is closely associ-
ated with insulin resistance  [15] . Our data however did not 
show an association between the  INS VNTR genotype 
and different parameters of body composition in early 
childhood. Our findings are in line with a large German 
 [1] and Finnish  [6] study, which also failed to confirm an 
association between a polymorphism in  INS VNTR and 
body composition. These inconsistent findings are not 
likely to be explained by ethnic differences in VNTR sub-
class composition, presence (or absence) of nearby modi-
fying variants, or variable local linkage disequilibrium 
relationships because these are known to be broadly sim-
ilar in all non-African populations  [21] . Another expla-
nation could be that biological differences between the 
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 Fig. 2.  IGF1 gene promoter region poly-
morphism and body composition in early 
childhood.  a–c Mean differences (and the 
95% CI) in body composition according to 
 IGF1 genotype at 6 weeks and 24 months 
of age based on multiple linear regression 
models. The homozygous group is used as 
reference group and the models are adjust-
ed for gender and age. HZ = Heterozygous, 
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various study samples (e.g., environmental exposures,
antenatal management, secular trends) and/or to study 
design-related issues (accuracy and choice of measure-
ments of body composition) have an effect on the power 
to detect VNTR association effects.
 In the present study, we did not find an association 
between  INS VNTR and  IGF1 gene polymorphisms and 
different parameters of body composition. These find-
ings are in line with our previous reports, in which we 
described no association between  INS VNTR and  IGF1 
gene polymorphisms with weight and height at various 
ages from fetal life until infancy  [4, 13] . Landmann et al. 
 [1] found that the absence of the common 192-bp allele of 
the  IGF1 gene is associated with an accelerated weight 
gain in the first year of life. Vaessen et al.  [9] found that 
the absence of the 192-bp allele was associated with a de-
creased adult height. In the same cohort, noncarriers had 
a lower birth weight  [10] . These differences could be ex-
plained by differences in study design. One of the major 
strengths of our study is that we examined the association 
of the  IGF1 gene promoter polymorphism with different 
parameters of body composition rather than, as previ-
ously performed, with only birth or postnatal weight. 
Measurements of body composition give a more complete 
picture of the distribution of fat mass, because they pro-
vide regional data instead of whole body data. Health 
risks associated with overweight are now known to derive 
primarily from fat rather than weight  [33] . Body compo-
sition is therefore a better risk indicator for developing 
overweight of obesity  [34, 35] .
 Recently, Voorhoeve et al.  [11] examined the associa-
tion between the  IGF1 gene polymorphism and body fat-
ness. They found that body weight, BMI, fat mass, waist 
circumference and hip circumference were higher in fe-
male variant carriers of the  IGF1 polymorphism. A simi-
lar trend was seen in boys. We could not replicate these 
findings, even after using the same stratification. This 
could be explained by the difference in age of the subjects. 
The subjects in the study of Voorhoeve were between 10.7 
and 13.6 years as we examined subjects until the age of 2 
years. Furthermore, the subjects of Voorhoeve were born 
between 1981 and 1989, while our subjects were born be-
tween 2003 and 2005. In line with Voorhoeve, we expect-
ed that our younger cohort would show a stronger rela-
tionship between the  IGF1 genotype and body composi-
tion, because it is known from recent epidemiological 
studies that the prevalence of overweight and obesity is 
increasing worldwide. The discrepancy between our re-
sults and the results of Voorhoeve could mean that it 
takes some time to develop the differences in body com-
position based on  IGF1 genotype. At the age of 2 years, 
the differences between genotypes are not yet present. It 
is also possible that the differences between genotypes 
found by Voorhoeve are significant by chance because 
they were very small. Thus far, our and previous studies 
show rather inconsistent associations with growth char-
acteristics in early life. Chance findings cannot therefore 
be excluded. Further studies in larger cohorts are neces-
sary to study the effect of this  IGF1 promoter polymor-
phism with growth from fetal to early postnatal life.
 In conclusion, this study demonstrates that a poly-
morphism in the  INS VNTR and  IGF1 gene is not associ-
ated with body composition in early childhood. Longer 
follow-up studies are needed to examine whether and at 
which age differences develop in body composition be-
tween polymorphisms in the  INS VTNR and  IGF1 geno-
type. Currently, studies are being performed for further 
follow-up measurements in our cohort. Also systematic 
searches for disease-associated common variants by 
means of genome-wide association studies may enable us 
to purchase a more complete understanding of the entire 
 IGF1 and  VNTR-INS-IGF2 region and its relationship to 
growth and morbidity in childhood and later life.
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